Too big to prosecute

TL;DR

McKesson Corporation's role in the opioid crisis exposes regulatory failures and industry accountability issues.

Transcript

60 minutes rewind in October we joined forces with the Washington Post and reported a disturbing story of Washington at its worst about an act of Congress that crippled the de A's ability to fight the worst drug crisis in American history the opioid addiction crisis now a new front of that joint investigation it is also disturbing it's the inside s... Read More

Key Insights

• 🤨 McKesson's negligence in reporting suspicious orders contributed significantly to the opioid epidemic.
• 🥹 The DEA faced legal pressures and challenges in holding McKesson accountable for its role in the crisis.
• 💖 A $150 million fine on McKesson sparked outrage for being inadequate in addressing the severity of their actions.
• 🥹 State attorneys general are taking legal action against the pharmaceutical industry to hold them accountable for the epidemic.

Questions & Answers

Q: What was McKesson's involvement in the opioid crisis?

McKesson distributed vast amounts of opioids without due diligence, supplying pharmacies and doctors linked to criminal drug rings, fueling addiction and overdoses nationwide.

Q: Why did the DEA's case against McKesson face challenges?

The DEA's attempt to hold McKesson accountable hit a brick wall in Washington due to legal pressures, leading to a significantly reduced fine compared to the severity of the offense.

Q: What implications does McKesson's lenient settlement have?

The $150 million fine on a company of McKesson's scale seems inadequate, raising concerns of special treatment and lack of industry accountability in the ongoing opioid crisis.

Q: What actions are being taken to address the pharmaceutical industry's role in the epidemic?

State attorneys general are suing the industry for accountability, highlighting the need for stricter regulations and penalties to combat the opioid crisis effectively.

Summary & Key Takeaways

• The DEA built a significant case against McKesson for fueling the opioid crisis.

• McKesson failed to report suspicious orders and supplied pills to criminal drug rings.

• Despite evidence, McKesson received a lenient $150 million fine, raising questions of accountability.